Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02753283 · ClinicalTrials.gov registry record · Phase 4
Preventing Osteoporosis Using Denosumab
A Phase 4 study, sponsored by Susan L. Greenspan.
- Completed
- Registry status
- Phase 4
- Development phase
- 201
- Enrollment target
NCT02753283 is a Phase 4 study that has completed, run by Susan L. Greenspan. The registered enrollment target is 201 participants.
The verdict
NCT02753283, a Phase 4 study, has completed, sponsored by Susan L. Greenspan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 201 participants
- Enrollment target
Study Summary
The purpose of this research study is to find out if denosumab (Prolia®), an injection given in the arm under the skin every 6 months, works to treat bone loss and prevent it from worsening in older men and women (ages 65 and older) who have osteoporosis and reside in long-term care (LTC) facilities.
Interventions
- DRUG Placebo
- DRUG denosumab
- DIETARY_SUPPLEMENT Calcium and Vitamin D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2016-06 |
| Est. Completion | 2023-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02753283
The ClinicalTrials.gov registry entry for NCT02753283 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Susan L. Greenspan, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02753283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02753283 about?
NCT02753283 is a clinical study titled "Preventing Osteoporosis Using Denosumab". The purpose of this research study is to find out if denosumab (Prolia®), an injection given in the arm under the skin every 6 months, works to treat bone loss and prevent it from worsening in older men and women (ages 65 and older) who have osteoporosis and reside in long-term care (LTC) facilities...
What is the current status of trial NCT02753283?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 201 participants. The study started on 2016-06. Estimated completion is 2023-08.
What interventions are being tested in trial NCT02753283?
The interventions under investigation include: Placebo (DRUG), denosumab (DRUG), Calcium and Vitamin D (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02753283?
This trial is sponsored by Susan L. Greenspan, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.